戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ure (NCPAP) or intubate-surfactant-extubate (INSURE).
2 9.8% of survivors and 92.1% of siblings were insured.
3 outpatient encounters among the commercially insured.
4  were primarily female, Latino, and publicly insured.
5 rance, whereas 43,136 (70.9%) were privately insured.
6  51% female, 46% non-White, and 74% publicly insured.
7 on rate fell in the middle between privately insured (24.1%) and publicly insured or noninsured US pa
8 he projected incident population of publicly insured 3-year-olds in the US over 10 years with costs d
9 tinx, 3.7% Asian), of which 376 (99.2%) were insured (34.3% private, 41.2% public, 23.8% public with
10 ,325 [95.8%]), female (406 158 [71.1%]), and insured (567,361 [99.4%]) and had Charlson Comorbidity I
11 and by the mean daily dose of vasopressor to insure a mean arterial pressure of 65-75 mm Hg.
12 ise may promote stress resilience in part by insuring a more rapid and shortened HPA response to a st
13 in, such as transcription and remodeling, to insure accurate duplication of both genetic and epigenet
14 vidence that SWIP-13 acts presynaptically to insure adequate levels of surface DAT expression and DA
15 c oxide-the three-gas respiratory cycle-that insures adequate oxygen and nutrient delivery to meet lo
16  1 to December 31, 2012, of 13,103 privately insured adolescents aged 13 to 21 years (mean [SD] age,
17 ective medical record review of continuously insured adolescents aged 15 to 19 years experiencing pre
18  about health care expenditures of privately insured adolescents, especially those who incur high cos
19 ercial claims database included commercially insured adults (aged 18-64 years) from January 1, 2001,
20         Participants: Uninsured and Medicaid-insured adults aged 18 to 64 years.
21                       Uninsured and Medicaid-insured adults aged 18 to 64 years.
22                                 Commercially insured adults have been visiting PCPs less often, and n
23 -2 receptor antagonists (H2RAs) in privately insured adults in the United States.
24                                              Insured adults receive invasive cardiovascular procedure
25       The cohort was limited to commercially insured adults.
26              Relative patterns for privately insured African American versus white donors were simila
27 ns, some policies such as public finance can insure against catastrophic health expenditures.
28 still apply higher doses than the optimum to insure against losses in high disease seasons.
29  Routine extraperitonealization of the graft insured against graft-torsion (0%) despite a transperito
30 ically significant differences between early INSURE and NCPAP alone for all outcomes assessed.
31 cs (odds ratio, 0.74 [95% CI, 0.60-0.91] for insured and 0.58 [95% CI, 0.36-0.94] for uninsured) pers
32 ks (odds ratio, 0.74 [95% CI, 0.64-0.86] for insured and 0.59 [95% CI, 0.36-0.94] for uninsured) and
33 y (approximately 13 000 of whom are Medicaid insured and 6000 of whom are cared for in Cincinnati Chi
34 were $4762 and $6705 for commercial/Medicare-insured and Medicaid patients, respectively (P=0.176 and
35 laims data for over 100 million commercially insured and Medicare Advantage individuals, was used to
36 a who received an APCD who were commercially insured and Medicare managed care enrollees from a large
37            Older, obese, uninsured, Medicaid-insured and patients at for-profit centers were more lik
38 ociodemographically advantaged and privately insured and to live in regions with reduced access to de
39 recover such uncompensated costs of Medicaid-insured and uninsured patients.
40 nwhite, and unmarried than patients who were insured and were also more likely to be from regions of
41 er EDs were less likely to be transferred if insured and were at risk of receiving suboptimal trauma
42 PI patients in Cohort 1 (primarily privately insured) and Cohort 2 (includes Medicare and/or Medicaid
43 r uninsured and 0.85 [95% CI, 0.84-0.87] for insured) and Hispanic patients (odds ratios, 0.72 [95% C
44 n = 3631) Medicare, 48% (n = 3667) privately insured, and 4% (n = 331) Medicaid patients.
45 s were primarily minority, 88% were publicly insured, and 58% were from Spanish-speaking families.
46 CI = 1.42, 1.83), as did non-White, publicly insured, and lower income children.
47 eria, 57.1% were white, 48.8% were privately insured, and most were 45 years and older (51.3%).
48 s likely to receive LVADs than the privately insured, and patients in low-income ZIP codes were less
49 than were patients who were white, privately insured, and treated at a high-volume facility, respecti
50                              Among privately insured beneficiaries requiring procedural intervention
51 ed a retrospective cohort study of privately insured beneficiaries who had an emergency department vi
52  replicated analyses on 881,381 commercially insured beneficiaries.
53 e survival difference was significant in the insured but not in the uninsured patients.
54 d CAD imaging tests for consecutive patients insured by 1 large private payer.
55 ans Health Administration, $5976 among those insured by a Medicare health maintenance organization, $
56                       Cell-shape changes are insured by a thin, dynamic, cortical layer of cytoskelet
57  specialty care, with caregivers of children insured by CHIP reporting the highest rates of difficult
58 oportion of endocrine surgeons' patients are insured by commercial plans (46%-50%), and payer mix is
59       Retrospective cohort study of patients insured by Harvard Pilgrim Health Care (HPHC), a large n
60  [75%-78%]) than were caregivers of children insured by Medicaid (26% [23%-28%]; P < .01) or CHIP (38
61  and white (89% vs. 63%), and were primarily insured by Medicaid (38%) or uninsured (35%).
62       Patients with DU-IE were predominantly insured by Medicaid (68.3% vs 13.4% for non-DU-IE), they
63            DU-IE patients were predominantly insured by Medicaid (68.3% vs 13.4%, P < 0.001).
64  adjusted probabilities [95% CIs]), children insured by Medicaid and CHIP were significantly more lik
65  child's needs (63% [60%-67%]) than children insured by Medicaid or CHIP.
66  after a cancer diagnosis ($2116 among those insured by Medicaid, $2367 among those insured by the Ve
67 % [32%-41%]) than did caregivers of children insured by Medicaid, and a lower likelihood of insurance
68                  In a large cohort of youths insured by Medicaid, the use of SSRIs or SNRIs-the most
69 administrative claims for Michigan residents insured by Medicare fee-for-service and Blue Cross Blue
70 ecipients were younger and more likely to be insured by Medicare than those without SOT.
71   Scabies ED patients that were male, older, insured by Medicare, from the highest income quartile, a
72 kely to be black, have pulmonary disease, be insured by the Centers for Medicaid and Medicare Service
73  21-87 years with incident diabetes who were insured by the largest health maintenance organization i
74 those insured by Medicaid, $2367 among those insured by the Veterans Health Administration, $5976 amo
75 ap insurance coverage, and $8115 among those insured by traditional fee-for-service Medicare but with
76 g this data, we identified 518,195 privately insured, cancer-free, and opioid-naive (no filled opioid
77 ospitalization compared with UC in privately insured cardiac patients overall.
78                                  Conclusion: Insured CHB patients were older, had more comorbidities,
79 ncial losses from inpatient care of Medicaid-insured children (defined as the reimbursement minus the
80 6%-79%]; P < .01) visits than were privately insured children (medical, 83% [82%-84%]; dental, 73% [7
81 cs and type 2 diabetes (outcome) in Medicaid-insured children aged 10-18 years across the United Stat
82                             For commercially insured children aged 12 to 18 years from all 50 states
83 's hospitals, small anticipated increases in insured children are unlikely to offset the reductions i
84 tudy population included mostly commercially insured children from birth to <24 months of age in 2010
85 ated ambulatory encounter claims of Medicaid-insured children in 34 Ohio counties in 2014.
86 rimary molar sealant strategies for publicly insured children using an "expected value of perfect inf
87                      Caregivers of privately insured children were also significantly more likely to
88 needed to identify the subgroups of publicly insured children who would benefit the most from this ef
89 osts, but it suggests that many commercially insured children with ASD remain undiagnosed or are bein
90            In this large sample of privately insured children with older siblings, receipt of the MMR
91 challenges were also magnified for privately insured children with special health care needs, whose c
92 n of this preventive approach among publicly insured children would result in large opportunity losse
93          In a very large sample of privately insured children, AT was associated with significant imp
94 omplex in rrn operons is as an RNA chaperone insuring co-ordination of 16S rRNA folding and RNase III
95 ion privately insured individuals in 69 self-insured companies spanning diverse industries.
96 n at 22 weeks' gestation or greater who were insured continuously for 3 months or more before pregnan
97 ad less outpatient care than their privately insured counterparts.
98 broad-spectrum antibiotics are often used to insure coverage of all potential organisms, carrying ris
99 that the higher bills are mainly ascribed to insured customers being less likely to be concerned abou
100 itals had a higher median number of Medicaid-insured discharges (4082; interquartile range [IQR], 352
101  included 1485 hospitals and 843725 Medicaid-insured discharges.
102                                              INSURE does not appear to increase CLD and/or death, CLD
103 r donation in the Medicare- versus privately insured donors included the following: malignant hyperte
104                           Among the Medicare-insured donors, 8% were African American and 5.7% were H
105                       Among the commercially insured, DTCA was positively and significantly associate
106 Nearly all patients in the final sample were insured during treatment.
107 ghtly regulated by the DA transporter (DAT), insuring efficient DA clearance after release.
108 re spending and resource use by a large self-insured employer that reduced statin copayments for pati
109 arting in 2009 with spending among privately insured enrollees in control states.
110 ed as either Medicaid enrollees or privately insured enrollees seeking new-patient primary care appoi
111 adjustment disorder (N=19,094) and privately insured enrollees unaffected by the policy in a comparis
112 ng Medicare fee-for-service and commercially insured enrollees.
113 els regulates LCRs and Ca transient decay to insure fail-safe pacemaker cell operation within a wide
114 ion, and asthma by splitting medication with insured family members.
115 ective cross-sectional analysis of privately insured female patients undergoing immediate breast reco
116 egregation require continual surveillance to insure fidelity.
117 ility were enhanced and the release could be insured from solid complex in aqueous solution.
118 ribution of replication initiation events to insure genomic stability.
119 e were more likely to: be younger, privately insured, have no comorbidities, pT3 disease, positive ly
120 nd Long Term Care, the third-party payer for insured health services in Ontario, Canada.
121  immune repertoire profiling is essential to insure high quality input for downstream analysis.
122  Total direct medical expenses for privately insured high-cost adolescents are associated with medica
123  cross-sectional analysis evaluated Medicaid-insured hospital discharges of patients 20 years and you
124  from 2010-2013 of 502,949 patients who were insured in the United States by 18 employers who provide
125 ; 95% CI, 1.72-1.91) compared with privately insured individuals ( P<0.001 for both).
126 om the OptumLabs Data Warehouse of privately insured individuals and Medicare Advantage enrollees.
127 maging utilization trends among commercially insured individuals are similar to those in Medicare enr
128                              Among privately insured individuals below age 65, ID consultations durin
129 mong Medicaid beneficiaries versus privately insured individuals hospitalized with ST-segment-elevati
130 laims database includes 14 million privately insured individuals in 69 self-insured companies spannin
131 thors compared expenditures for commercially insured individuals in four Oregon health plans from 200
132 ugh 2008 and a matched group of commercially insured individuals in Oregon who were exempt from parit
133 oconus (KCN) among a large, diverse group of insured individuals in the United States.
134                      Patients were privately insured individuals less than 65 years old with an acute
135  doctors, which in turn led to the right for insured individuals to freely choose their health-care p
136 l database of insurance claims for privately insured individuals under age 65, locating inpatient acu
137                                              Insured individuals were more likely to report having a
138  income (serving general public vs privately insured individuals) and ICU size (ten or fewer beds vs
139 n-hospital mortality compared with privately insured individuals.
140         For our subsample of FSCHs, Medicaid-insured inpatient financial losses were calculated with
141 fine CNT tips with their cylindrical surface insures intimate contact at CNT-SiO2 interface.
142 her possible way to improve food quality and insure its security.
143                            Data for Medicare-insured kidney transplant recipients in 2000 to 2007 (n=
144 States Renal Data System records of Medicare-insured kidney transplant recipients in 2000 to 2011 to
145 ith 5 fewer bariatric operations per 100,000 insured lives; this association was strongest in plans w
146                               Estimated U.S. insured losses due to severe thunderstorms in the first
147 f completed foreclosure among a continuously insured managed-care population of persons with type 2 d
148         A total of 205 commercially/Medicare-insured matched pairs and 136 Medicaid matched pairs wer
149 lthcare experience of nontargeted, privately insured Medicare Advantage patients.
150  Retrospective review of 73,002 commercially insured members of the IBM MarketScan commercial claims
151                     Of 17228599 commercially insured men in the 75 DMAs, 1007990 (mean age, 49.6 [SD,
152           Insured women are less likely than insured men to receive surgical intervention for an RRD.
153 ter surgical intervention in the universally insured military system, versus the civilian setting in
154                      Newborns from privately insured mothers treated with glyburide were more likely
155 32,060; IQR, 6.7%-37.0%), and 58.7% publicly insured (n = 106,116; IQR, 50.4%-67.8%).
156 nish speaking (n = 2297; 58.3%) and publicly insured (n = 3801; 92.1%).
157 ng the onset of acute respiratory failure to insure need for ongoing ventilatory support.
158 use of targeted therapeutics among privately insured nonelderly patients with cancer receiving chemot
159 caid is integral to public health because it insures one in five Americans and half of the nation's b
160 ts were infrequent given the large number of insured ophthalmologists and the large number of surgica
161 ntly, no evidence suggests that either early INSURE or NCPAP alone is superior to the other.
162 tween privately insured (24.1%) and publicly insured or noninsured US patients (30.4% and 31.2%, resp
163  a procedure that is highly used by publicly insured or uninsured patients.
164 om poorer neighborhoods or who were publicly insured or uninsured were less likely to receive care fr
165  risk (RR) estimates appeared to favor early INSURE over NCPAP alone, with a 12% RR reduction in CLD
166 s women (P<0.001), 1.25 for uninsured versus insured (P=0.06), 0.70 for Hispanics versus non-Hispanic
167 d for branded, prescription medication by an insured patient is set by the patient's insurance compan
168 rs posed as either a Medicaid or a privately-insured patient with symptoms of an incarcerated inguina
169              Adequate risk management should insure patients' safety.
170 t and ICD implantation among 10 289 Medicare-insured patients >/=65 years of age with an EF</=35% dur
171 .5), uninsured patients compared to publicly insured patients (1.2; 1.1-1.4), teaching hospitals comp
172 underinsured/ uninsured patients compared to insured patients (16.8%/16.9% vs. 5.0%; P=0.001).
173 ed patients (71.7%) and lowest for privately insured patients (36.6%).
174  but increased more than 50% in commercially insured patients (from 33,599 in 2003 to 50,816 in 2009)
175 spectively, among Medicaid than commercially insured patients (P<0.02 for both).
176              We identified 5749 commercially insured patients aged 18 to 64 with chronic opioid use w
177                                              Insured patients aged 40 years or older with newly diagn
178 ewed growth of CT imaging among commercially insured patients aged 45-64 years and Medicare enrollees
179  for each modality, followed by commercially insured patients aged 45-64 years, then aged 18-44 years
180 care: -301 [95% CI: -510, -92]; commercially insured patients aged 45-64 years: -54 [95% CI: -69, -39
181 r Medicare: 17 [95% CI: 6, 28]; commercially insured patients aged 45-64 years: 11 [95% CI: 2, 20]).
182 idence interval {CI}: 34, 148]; commercially insured patients aged 45-64 years: 158 [95% CI: 130, 186
183 ed hospice, fewer than one third of Medicaid-insured patients ages 21 to 64 years enrolled in hospice
184               Physicians may benefit because insured patients are more likely to have a regular sourc
185 ts) and a sample of 5.5 million commercially insured patients between 2003 and 2009.
186 s of opioid use among working-age, privately insured patients diagnosed with MBC.
187                         Among 20976 Medicare-insured patients discharged alive after acute MI, 10381
188 less likely to be transferred than privately insured patients for 4 diagnoses: biliary tract disease
189 r 30-day readmission rates, and commercially insured patients had even lower rates.
190                                        These insured patients had inpatient and/or outpatient claims
191 or colorectal cancer compared with privately insured patients in both Massachusetts and the control s
192               The comparison group comprised insured patients in California between 2006-2009 who wer
193 trumental variables analysis of commercially insured patients in the IBM MarketScan claims database f
194                      38 911 718 commercially insured patients in the OptumInsight Clinformatics Datab
195 n database to select 59,016,145 commercially insured patients in the United States between 2007 and 2
196                              Among privately insured patients less than 65 years old, treated in a ho
197                                              Insured patients often pay a percentage of the list pric
198 icare and for roughly 9 million commercially insured patients per year.
199 n insurance claims data for 678220 privately insured patients receiving chemotherapy before and after
200 ent leads to better outcomes among privately insured patients under age 65 years hospitalized with co
201 ing demands of an aging population and newly insured patients under the ACA.
202                                     Medicare-insured patients undergoing kidney transplant became inc
203 ntal costs in the SOT-HZ commercial/Medicare-insured patients were $5335 (P<0.001), and that in nonca
204 ting criteria were enrolled in S-OPAT, while insured patients were discharged to H-OPAT settings.
205                             The commercially insured patients were divided into two populations: thos
206                                    Privately insured patients were least likely to experience a delay
207  this retrospective analysis of commercially insured patients who had undergone elective surgery at i
208 erize how UCCs manage Medicaid and privately insured patients who present with an emergent condition.
209                                    Privately insured patients who receive care from in-network physic
210        We performed a retrospective study of insured patients who received care from a large health s
211  analyses by insurance status, non-privately insured patients who resided in areas with low density o
212               We identified 101 332 Medicare-insured patients who underwent their first kidney transp
213 lating a hypothetical cohort of commercially insured patients who were discharged from the hospital a
214                        Only half of Medicare-insured patients with AMI were enrolled in Part D by hos
215                                              Insured patients with diabetic retinopathy were seen by
216     In this cohort, there was an increase in insured patients with severe sepsis and septic shock pos
217 nd a larger proportion of White or privately insured patients).
218 d patients (20.8%; 95% CI, 15.5% to 26.9%; v insured patients, 35.3%; 95% CI, 33.8% to 36.9%).
219 wering therapy, respectively, than privately insured patients, and patients with public insurance wer
220 s have led to higher prices for commercially insured patients, but research about effects on quality
221 ential overuse in whites, men, and privately insured patients, in addition to underuse in disadvantag
222            In a large cohort of commercially insured patients, sleeve gastrectomy had a superior safe
223 reduced to 50% of that observed in privately insured patients, the strategy of extending drug coverag
224                      Compared with privately insured patients, those who had Medicare (adjusted OR: 0
225                      Compared with privately insured patients, uninsured patients (OR 0.52, P < 0.01)
226     No changes were detected among privately insured patients.
227 my, and lower survival relative to privately insured patients.
228 g a large and diverse cohort of commercially insured patients.
229 onally representative cohort of commercially insured patients.
230 referred directly to the ED versus privately insured patients.
231 e, when compared with publicly and privately insured patients.
232 R=2.12, 95% CI 1.08-4.15) than for privately insured patients.
233 tion rates between Medicare and commercially insured patients.
234 tion of bariatric surgery among commercially insured patients.
235 milar results were observed for commercially insured patients.
236 ssion within 30 days after PCI compared with insured patients.
237  hospitalizations and ED visits for Medicaid-insured pediatric patients residing in Hamilton County,
238                                Compared with insured pediatric patients with a traumatic brain injury
239 talizations and ED visits per 10000 Medicaid-insured pediatric patients.
240 asthma outcomes for a population of Medicaid-insured pediatric patients.
241 s had a slightly shorter length of stay than insured people and were less likely to receive five of t
242 tio, 1.43; 95% CI, 1.37-1.47) than privately insured people.
243 r uninsured and 0.81 [95% CI, 0.79-0.84] for insured) persistently initiated hemodialysis with an AVF
244 estimate uptake each year among commercially insured persons during 2010-2014.
245  diabetes mellitus in a dataset of 9,413,620 insured persons, representing nearly the full population
246 matched cohort analysis in a US commercially insured population (01 August 2004 to 31 December 2010),
247 trative claims data, a commercially/Medicare-insured population of patients with SOT between January
248 rsened glycemic control in this continuously insured population with diabetes.
249  use of coping mechanisms were common in our insured population with multiple myeloma.
250 ed steadily since 2012, among a commercially insured population, black race and low household income
251                                      In this insured population, many patients at high risk for macul
252 ng administrative claims from a commercially insured population, which may have a different prevalenc
253 e therapy in either Medicare or commercially insured populations in hospital or nonhospital settings.
254 idence-based pharmacotherapy to commercially insured post-myocardial infarction patients has the pote
255        In a population of primarily Medicaid-insured pregnant women managed by a cardio-obstetrics te
256   Evidence from this large study of publicly insured pregnant women may be consistent with a potentia
257 andards that both protect human subjects and insure public trust and support.
258 nce saves lives: The odds of dying among the insured relative to the uninsured is 0.71 to 0.97.
259 ry determinants that must work in concert to insure robust and tightly controlled expression from a c
260 ng unrelated living donors in this privately insured sample.
261 ly to be younger, African American, publicly insured, single, and less well educated.
262 all 60 653 pregnant women who had a Medicaid-insured singleton birth between January 1 and December 3
263 active, noninfectious, non-Behcet's uveitis (INSURE study); and 125 patients with quiescent, noninfec
264 reduction in ISM score versus placebo in the INSURE study, although no statistical analysis of the di
265 w, secukinumab 150 mg q4w, or placebo in the INSURE study; or secukinumab 300 mg q2w, secukinumab 300
266  with the ACA (12.1% of uninsured v 29.0% of insured survivors; odds ratio, 2.86; 95% CI, 1.28 to 6.3
267 ten institutional protocols are important to insure that patients receive the optimal care.
268 ic intervention, studies must be designed to insure that the prevention is not merely cosmetic.
269                            The 2913 subjects insured that the bootstrap estimates were statistically
270 rplay and spatial gradients of these factors insures that crypt epithelial cell proliferation and dev
271 ous, rigorous framework must be imposed that insures that such research is done following the highest
272  seems to play an important adaptive role in insuring that the strength of our memories will reflect
273 -renew to maintain the stem cell pool and to insure the continuous replenishment of blood cells.
274 lls lines and using dose-response curves, to insure the fidelity and robustness of this approach for
275        These and other qualities, which have insured the sustainable and healthy nourishment of anima
276 d timing cues with high temporal fidelity to insure their coincident arrival at the binaural targets.
277 e female-biased and invest more in sepals to insure their own seed set.
278                      Most women (74.2%) were insured through Medicaid.
279                            Data for Medicare-insured transplant recipients in 2000 to 2007 (n=45,250)
280 age was estimated from a cohort of privately insured transplant recipients who receive lifelong immun
281  coverage compared with a cohort of Medicare-insured transplant recipients, using multivariable survi
282                        Among 14,041 Medicare-insured transplants in 2000 to 2007, 119 non-donor-A2 AB
283         Patients who were younger, privately insured, treated at an academic center, and had lower tu
284                           But even among the insured, underinsurance is now recognized as a major bar
285                              Compared to the insured, uninsured patients have worse functional outcom
286                                    Privately insured US children in a large claims database were foll
287 gible adult participants who were continuous insured users between July 1, 2010 and March 31, 2012 wi
288 mic factors with DOAC use among commercially insured venous thromboembolism patients.
289 men vs men (OR: 2.00; 95% CI: 1.88-2.13) and insured vs uninsured participants (OR: 2.12; 95% CI: 1.8
290 had a diagnosis of asthma, and were Medicaid insured were studied.
291 ured patients (reference category, privately insured) while patient- and hospital-level factors were
292 ndomized clinical trials that compared early INSURE with NCPAP alone in preterm infants who had never
293 ere sent to 2150 persons above the age of 55 insured with a German medical insurance company in the a
294 ed public subsidies; 21.7% were commercially insured with household incomes at or below 250% of the f
295 ercentage living in a rural area, percentage insured with Medicaid, percentage uninsured, and total p
296 artile 2: 1.19 [1.07-1.32], P < .001), being insured with Medicare (1.56 [1.41-1.74], P < .001) or Me
297                                              Insured women are less likely than insured men to receiv
298 pronounced among younger, educated, and well-insured women, and reflects fear of recurrence and in so
299 072 visits to emergency departments by newly insured young adults and $147 million in associated cost
300 ospice use among patients in Medicaid, which insures younger and indigent patients, relative to those
301        Nonetheless, only 1 in 4 commercially insured youth with OUD received pharmacotherapy, and dis

 
Page Top